Screener
Chemours CC Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Chemours in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Chemours’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 11:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001627223-26-000024
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Amortization of debt issuance costs and issue discounts | 5 | 6 |
| Deferred tax provision | 238 | 97 |
| Asset-related charges | 1 | 11 |
| Stock-based compensation expense | 14 | 12 |
| Net periodic pension (income) cost | (1) | — |
| Defined benefit plan contributions | (1) | (8) |
| Other operating charges and credits, net | (9) | 14 |
| Decrease (increase) in operating assets: |
Item 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS
FAQ
- What is Chemours's stock-based comp?
- Chemours (CC) reported stock-based comp of $7M in Q2 2026.
- How has Chemours's stock-based comp changed year-over-year?
- Chemours's stock-based comp decreased by 0.0% year-over-year, from $7M to $7M.
- What is the long-term trend for Chemours's stock-based comp?
- Over 4 years (2021 to 2025), Chemours's stock-based comp has grown at a -11.3% compound annual growth rate (CAGR), from $34M to $21M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Chemours's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude